Catherine Ramsey
Stock Analyst at Baird
(2.22)
# 1096
Out of 5,243 analysts
44
Total ratings
65.52%
Success rate
27.50%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Twist Bioscience | Maintains: Outperform | 46 48 | 45.33 | 5.89% | 5 | Nov 19, 2024 | |
Natera | Maintains: Outperform | 120 160 | 170.38 | -6.09% | 5 | Nov 13, 2024 | |
Illumina | Maintains: Neutral | 124 139 | 136.22 | 2.04% | 4 | Nov 6, 2024 | |
Revvity | Maintains: Outperform | 136 138 | 118.88 | 16.08% | 3 | Nov 5, 2024 | |
Castle Biosciences | Maintains: Outperform | 37 39 | 25 | 56% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 319 312 | 397.49 | -21.51% | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 3 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 695 665 | 551.61 | 20.56% | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 160 | 142.18 | 12.53% | 5 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 75 | 53.52 | 40.13% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 20 | n/a | n/a | 2 | Apr 24, 2020 |